Concepedia

Veena Shankaran

VS

49

Publications

9.2K

Citations

29

H-Index

2007

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of Washington Medical Center

Merck & Co., Inc., Rahway, NJ, USA (United States)

Seattle Cancer Care Alliance

Veena Shankaran is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2024

49

Publications

49

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.7K citations · Full text

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

, , +7

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro, Hyun Cheol Chung, Veena Shankaran et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

, , +5

Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer

Scott D. Ramsey, Aasthaa Bansal, Catherine R. Fedorenko et al. · Journal of Clinical Oncology · 2016 · 859 citations

Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis

Veena Shankaran, Sanjay Jolly, David K. Blough et al. · Journal of Clinical Oncology · 2012 · 283 citations

Rows per page

1–5 of 49